

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 60mg | 56 pill | $28.64 | $2,005.15 $1,604.12 Best Price Popular | |
| 60mg | 28 pill | $33.95 | $1,188.15 $950.52 |
Daclatasvir is an innovative medication used primarily for the treatment of hepatitis C virus (HCV) infection. It belongs to a class of drugs known as NS5A inhibitors, which target a specific protein essential for viral replication. This medication has gained recognition for its high efficacy and favorable safety profile, making it a popular choice among healthcare providers and patients alike.
By acting on the NS5A protein, Daclatasvir disrupts the replication process of the hepatitis C virus. This action impairs the virus's ability to multiply within the body, reducing the viral load significantly. When used in combination with other antiviral agents, Daclatasvir can lead to a sustained virologic response, effectively clearing the infection in many cases.
Typically, Daclatasvir is prescribed as a part of a combination therapy regimen tailored to the specific HCV genotype and the patientβs health condition. The standard dose is usually 60 mg once daily, but this can vary depending on the treatment plan prescribed by a healthcare professional. It is crucial to follow the prescribed dosage schedule strictly to maximize the medication's effectiveness and minimize potential side effects.
One of the primary advantages of Daclatasvir is its high success rate in treating hepatitis C. Many patients experience a rapid decrease in viral load, leading to improved liver health and reduced risk of complications such as cirrhosis or liver cancer. Additionally, Daclatasvir generally has fewer side effects compared to older hepatitis C treatments, making it a more tolerable option for many.
Although Daclatasvir is well-tolerated by most patients, some may experience side effects. Common issues include headache, fatigue, nausea, and difficulty sleeping. Rarely, more severe reactions such as allergic responses or liver problems may occur. It is important to report any unusual symptoms to a healthcare provider promptly to ensure appropriate management.
Before starting Daclatasvir, patients should inform their healthcare provider of all medications they are taking, as certain drugs can interfere with its effectiveness. For example, medications containing potent inducers or inhibitors of certain enzymes may alter the drug's levels. Patients with underlying liver conditions or other health issues should also discuss these with their doctor to ensure safe usage.
Daclatasvir is regarded as a significant advancement in hepatitis C treatment. It offers a convenient oral regimen with a high cure rate and manageable side effects. When used under medical supervision and in combination with other antiviral agents, Daclatasvir provides a reliable pathway toward achieving viral eradication and improving liver health. Its role in modern antiviral therapy continues to make it a valuable medication for those affected by hepatitis C.
14β21 days. Free from $200.00 .
5β9 days. $30.00
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.